Covid-19 Impact on Global mRNA Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by mRNA Treatment Revenue
• 1.4 Covid-19 Implications on Market by Type
  • 1.4.1 Global mRNA Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Vaccine
  • 1.4.3 Drugs
• 1.5 Market by Application
  • 1.5.1 Global mRNA Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Protein Diseases
  • 1.5.3 Gene Dysfunction Diseases
  • 1.5.4 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): mRNA Treatment Industry Impact
  • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  • 1.6.2 Covid-19 Impact: Commodity Prices Indices
  • 1.6.3 Covid-19 Impact: Global Major Government Policy
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends

• 2.1 Covid-19 Implications on Global mRNA Treatment Market Perspective (2015-2026)
• 2.2 Covid-19 Implications on Global mRNA Treatment Growth Trends by Regions
  • 2.2.1 mRNA Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 mRNA Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 mRNA Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 mRNA Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key mRNA Treatment Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

• 3.1 Global Top mRNA Treatment Players by Market Size
  • 3.1.1 Global Top mRNA Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global mRNA Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global mRNA Treatment Market Concentration Ratio
  • 3.2.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2019
• 3.3 mRNA Treatment Key Players Head office and Area Served
• 3.4 Key Players mRNA Treatment Product Solution and Service
• 3.5 Date of Enter into mRNA Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

• 4.1 Global mRNA Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global mRNA Treatment Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

• 5.1 Global mRNA Treatment Market Size by Application (2015-2020)
• 5.2 Global mRNA Treatment Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

• 6.1 North America mRNA Treatment Market Size (2015-2020)
• 6.2 mRNA Treatment Key Players in North America (2019-2020)
• 6.3 North America mRNA Treatment Market Size by Type (2015-2020)
• 6.4 North America mRNA Treatment Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

• 7.1 Europe mRNA Treatment Market Size (2015-2020)
• 7.2 mRNA Treatment Key Players in Europe (2019-2020)
• 7.3 Europe mRNA Treatment Market Size by Type (2015-2020)
• 7.4 Europe mRNA Treatment Market Size by Application (2015-2020)

8 China Impact of COVID-19

• 8.1 China mRNA Treatment Market Size (2015-2020)
• 8.2 mRNA Treatment Key Players in China (2019-2020)
• 8.3 China mRNA Treatment Market Size by Type (2015-2020)
• 8.4 China mRNA Treatment Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

• 9.1 Japan mRNA Treatment Market Size (2015-2020)
• 9.2 mRNA Treatment Key Players in Japan (2019-2020)
• 9.3 Japan mRNA Treatment Market Size by Type (2015-2020)
• 9.4 Japan mRNA Treatment Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

• 10.1 Southeast Asia mRNA Treatment Market Size (2015-2020)
• 10.2 mRNA Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia mRNA Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia mRNA Treatment Market Size by Application (2015-2020)

11 India Impact of COVID-19

• 11.1 India mRNA Treatment Market Size (2015-2020)
• 11.2 mRNA Treatment Key Players in India (2019-2020)
• 11.3 India mRNA Treatment Market Size by Type (2015-2020)
• 11.4 India mRNA Treatment Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

• 12.1 Central & South America mRNA Treatment Market Size (2015-2020)
• 12.2 mRNA Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America mRNA Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America mRNA Treatment Market Size by Application (2015-2020)

13Key Players Profiles

• 13.1 CureVac
  • 13.1.1 CureVac Company Details
  • 13.1.2 CureVac Business Overview and Its Total Revenue
  • 13.1.3 CureVac mRNA Treatment Introduction
  • 13.1.4 CureVac Revenue in mRNA Treatment Business (2015-2020))
  • 13.1.5 CureVac Recent Development and Reaction to COVID-19
• 13.2 Moderna
  • 13.2.1 Moderna Company Details
  • 13.2.2 Moderna Business Overview and Its Total Revenue
  • 13.2.3 Moderna mRNA Treatment Introduction
  • 13.2.4 Moderna Revenue in mRNA Treatment Business (2015-2020)
  • 13.2.5 Moderna Recent Development and Reaction to COVID-19
• 13.3 BioNTech (Pfizer)
  • 13.3.1 BioNTech (Pfizer) Company Details
  • 13.3.2 BioNTech (Pfizer) Business Overview and Its Total Revenue
  • 13.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
  • 13.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2015-2020)
  • 13.3.5 BioNTech (Pfizer) Recent Development and Reaction to COVID-19
• 13.4 Sanofi (Translate Bio)
  • 13.4.1 Sanofi (Translate Bio) Company Details
  • 13.4.2 Sanofi (Translate Bio) Business Overview and Its Total Revenue
  • 13.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
  • 13.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2015-2020)
  • 13.4.5 Sanofi (Translate Bio) Recent Development and Reaction to COVID-19
• 13.5 Ethris (AstraZeneca)
  • 13.5.1 Ethris (AstraZeneca) Company Details
  • 13.5.2 Ethris (AstraZeneca) Business Overview and Its Total Revenue
  • 13.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
  • 13.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2015-2020)
  • 13.5.5 Ethris (AstraZeneca) Recent Development and Reaction to COVID-19
• 13.6 Kernal Biologics
  • 13.6.1 Kernal Biologics Company Details
  • 13.6.2 Kernal Biologics Business Overview and Its Total Revenue
  • 13.6.3 Kernal Biologics mRNA Treatment Introduction
  • 13.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2015-2020)
  • 13.6.5 Kernal Biologics Recent Development and Reaction to COVID-19
• 13.7 RaNA Therapeutics
  • 13.7.1 RaNA Therapeutics Company Details
  • 13.7.2 RaNA Therapeutics Business Overview and Its Total Revenue
  • 13.7.3 RaNA Therapeutics mRNA Treatment Introduction
  • 13.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2015-2020)
  • 13.7.5 RaNA Therapeutics Recent Development and Reaction to COVID-19
• 13.8 Silence Therapeutics
  • 13.8.1 Silence Therapeutics Company Details
  • 13.8.2 Silence Therapeutics Business Overview and Its Total Revenue
  • 13.8.3 Silence Therapeutics mRNA Treatment Introduction
  • 13.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2015-2020)
  • 13.8.5 Silence Therapeutics Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

15Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer